Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply

N Engl J Med. 2021 Apr 22;384(16):1578. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines*
  • COVID-19*
  • Humans
  • RNA, Messenger
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine